Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)

SHE:301263 Revenue

Guangdong Taienkang Pharmaceutical had revenue of 212.41M CNY in the quarter ending September 30, 2026, with 18.83% growth. This brings the company's total for the last twelve months to 681.75M, up 1.08% year-over-year. In the year 2025, Guangdong Taienkang Pharmaceutical had annual revenue of 674.90M, down -6.40%. That makes Guangdong Taienkang Pharmaceutical the 22,474th largest company in the world by revenue and 4,100th in China.

• Revenue (ttm): 681.75M
• Revenue Growth: +1.08%
• P/S Ratio: 13.43
• Revenue / Employee: 590.77K
• Employees: 1,154
• Market Cap: 9.15B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Agent 409.41M 60.7%
• Pharmaceutical Manufacturing 246.76M 36.6%
• Medical technology services and technology transfer 17.85M 2.6%
• Unallocated Other Operating Income 878.78K 0.1%

By Geography

Chart

• South China 291.43M 43.2%
• East China 162.89M 24.1%
• Central China 89.58M 13.3%
• North China 43.46M 6.4%
• Northwest China 34.46M 5.1%
• Southwest China 31.21M 4.6%
• Northeast China 20.09M 3.0%
• Export 1.78M 0.3%

Fiscal year ended Dec 31, 2025 See the full SHE:301263 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	674.90M	-46.13M	-6.40%
Jan 1, 2025	721.03M	-39.76M	-5.23%
Jan 1, 2024	760.79M	-22.69M	-2.90%
Jan 1, 2023	783.48M	129.83M	19.86%
Jan 1, 2022	653.65M	-55.33M	-7.80%

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error